Offer - Urjas Oil for just ₹ 1
Mucobar S is a commercial drug that is prescribed in the form of Syrup. Bronchitis, Sore Throat, Bad Breath are some of its major therapeutic uses. Secondary and off-label uses of Mucobar S have also been mentioned below.
The correct dosage of Mucobar S depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Common side effects of Mucobar S include Constipation, Heartburn, Nausea or vomiting. While these are the most often observed Mucobar S side effects, there are can be others also. These have been listed below. Normally, these side effects of Mucobar S are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Mucobar S is Moderate for pregnant women and Moderate for women who are breastfeeding. In addition, Mucobar S's effects on the liver, heart and kidney are discussed below in the Mucobar S related warnings section.
Mucobar S can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Mucobar S in conditions like Gastrointestinal Bleeding, Asthma, Smoking Addiction. The section on Mucobar S contraindications lists all such conditions.
Besides this, Mucobar S may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to the above precautions for Mucobar S, it is important to know that it is not safe while driving, and is not habit-forming.
Mucobar S is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Mucobar S safe for pregnant women?
Mucobar S can have harmful effects in pregnant women. If you experience any discomfort after using Mucobar S, then discontinue the use and take your doctor's advice.
Is the use of Mucobar S safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Mucobar S. Immediately discontinue Mucobar S if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Mucobar S on the Kidneys?
There are no side effects of Mucobar S on the kidneys.
What is the effect of Mucobar S on the Liver?
There are no any side effects of Mucobar S on the liver.
What is the effect of Mucobar S on the Heart?
You can take Mucobar S without any fear of damage to the heart.
Mucobar S should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Mucobar S unless your doctor advises you to do so -
Is this Mucobar S habit forming or addictive?
Forming a habit of Mucobar S has not been reported.
Interaction between Food and Mucobar S
Taking Mucobar S with food is safe.
Interaction between Alcohol and Mucobar S
It is difficult to say anything about the effect of Mucobar S and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 219
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 888
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Proventil® HFA (albuterol sulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 118-120
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Guaifenesin
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 629-631
